SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals

Background: Masculinising hormone therapy with testosterone is used to align an individual’s physical characteristics with their gender identity. Testosterone therapy is typically administered via intramuscular or transdermal routes and polycythaemia is the most common adverse event. Aims: To compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolan, Brendan J, Leemaqz, Shalem Y, Ooi, Olivia, Cundill, Pauline, Silberstein, Nicholas, Locke, Peter, Grossmann, Mathis, Zajac, Jeffrey D, Cheung, Ada S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208758/
http://dx.doi.org/10.1210/jendso/bvaa046.865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208758/
http://dx.doi.org/10.1210/jendso/bvaa046.865

Ejemplares similares